311 related articles for article (PubMed ID: 26471267)
21. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
[TBL] [Abstract][Full Text] [Related]
22. Inflammatory cytokine TSLP stimulates platelet secretion and potentiates platelet aggregation via a TSLPR-dependent PI3K/Akt signaling pathway.
Dong J; Lin J; Wang B; He S; Wu C; Kushwaha KK; Mohabeer N; Su Y; Fang H; Huang K; Li D
Cell Physiol Biochem; 2015; 35(1):160-74. PubMed ID: 25591759
[TBL] [Abstract][Full Text] [Related]
23. Nanoparticle-induced platelet aggregation and vascular thrombosis.
Radomski A; Jurasz P; Alonso-Escolano D; Drews M; Morandi M; Malinski T; Radomski MW
Br J Pharmacol; 2005 Nov; 146(6):882-93. PubMed ID: 16158070
[TBL] [Abstract][Full Text] [Related]
24. A humanized monoclonal antibody that inhibits platelet-surface ERp72 reveals a role for ERp72 in thrombosis.
Holbrook LM; Sandhar GK; Sasikumar P; Schenk MP; Stainer AR; Sahli KA; Flora GD; Bicknell AB; Gibbins JM
J Thromb Haemost; 2018 Feb; 16(2):367-377. PubMed ID: 29052936
[TBL] [Abstract][Full Text] [Related]
25. Platelet Shp2 negatively regulates thrombus stability under high shear stress.
Hu M; Liu P; Liu Y; Yue M; Wang Y; Wang S; Chen X; Zhou Y; Zhou J; Hu X; Ke Y; Hu H
J Thromb Haemost; 2019 Jan; 17(1):220-231. PubMed ID: 30444570
[TBL] [Abstract][Full Text] [Related]
26. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
Wang WY; Wu YC; Wu CC
Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
[TBL] [Abstract][Full Text] [Related]
27. The 19S Deubiquitinase inhibitor b-AP15 is enriched in cells and elicits rapid commitment to cell death.
Wang X; Stafford W; Mazurkiewicz M; Fryknäs M; Brjnic S; Zhang X; Gullbo J; Larsson R; Arnér ES; D'Arcy P; Linder S
Mol Pharmacol; 2014 Jun; 85(6):932-45. PubMed ID: 24714215
[TBL] [Abstract][Full Text] [Related]
28. CD44 sensitivity of platelet activation, membrane scrambling and adhesion under high arterial shear rates.
Liu G; Liu G; Alzoubi K; Chatterjee M; Walker B; Münzer P; Luo D; Umbach AT; Elvira B; Chen H; Voelkl J; Föller M; Mak TW; Borst O; Gawaz M; Lang F
Thromb Haemost; 2016 Jan; 115(1):99-108. PubMed ID: 26355696
[TBL] [Abstract][Full Text] [Related]
29. GDF-15 prevents platelet integrin activation and thrombus formation.
Rossaint J; Vestweber D; Zarbock A
J Thromb Haemost; 2013 Feb; 11(2):335-44. PubMed ID: 23231375
[TBL] [Abstract][Full Text] [Related]
30. RUC-4: a novel αIIbβ3 antagonist for prehospital therapy of myocardial infarction.
Li J; Vootukuri S; Shang Y; Negri A; Jiang JK; Nedelman M; Diacovo TG; Filizola M; Thomas CJ; Coller BS
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2321-9. PubMed ID: 25147334
[TBL] [Abstract][Full Text] [Related]
31. Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets.
Schwarz M; Meade G; Stoll P; Ylanne J; Bassler N; Chen YC; Hagemeyer CE; Ahrens I; Moran N; Kenny D; Fitzgerald D; Bode C; Peter K
Circ Res; 2006 Jul; 99(1):25-33. PubMed ID: 16778135
[TBL] [Abstract][Full Text] [Related]
32. Protease-activated receptor-4 (PAR4) variant influences on platelet reactivity induced by PAR4-activating peptide through altered Ca
Morikawa Y; Kato H; Kashiwagi H; Nishiura N; Akuta K; Honda S; Kanakura Y; Tomiyama Y
Thromb Res; 2018 Feb; 162():44-52. PubMed ID: 29289806
[TBL] [Abstract][Full Text] [Related]
33. Antithrombotic Effects of Combined PAR (Protease-Activated Receptor)-4 Antagonism and Factor Xa Inhibition.
Meah MN; Raftis J; Wilson SJ; Perera V; Garonzik SM; Murthy B; Everlof JG; Aronson R; Luettgen J; Newby DE
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2678-2685. PubMed ID: 32907366
[TBL] [Abstract][Full Text] [Related]
34. Methods for quantification of in vivo changes in protein ubiquitination following proteasome and deubiquitinase inhibition.
Udeshi ND; Mani DR; Eisenhaure T; Mertins P; Jaffe JD; Clauser KR; Hacohen N; Carr SA
Mol Cell Proteomics; 2012 May; 11(5):148-59. PubMed ID: 22505724
[TBL] [Abstract][Full Text] [Related]
35. Farnesoid X Receptor and Its Ligands Inhibit the Function of Platelets.
Moraes LA; Unsworth AJ; Vaiyapuri S; Ali MS; Sasikumar P; Sage T; Flora GD; Bye AP; Kriek N; Dorchies E; Molendi-Coste O; Dombrowicz D; Staels B; Bishop-Bailey D; Gibbins JM
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2324-2333. PubMed ID: 27758768
[TBL] [Abstract][Full Text] [Related]
36. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
[TBL] [Abstract][Full Text] [Related]
37. Sphingosine 1-Phosphate Produced by Sphingosine Kinase 2 Intrinsically Controls Platelet Aggregation In Vitro and In Vivo.
Urtz N; Gaertner F; von Bruehl ML; Chandraratne S; Rahimi F; Zhang L; Orban M; Barocke V; Beil J; Schubert I; Lorenz M; Legate KR; Huwiler A; Pfeilschifter JM; Beerli C; Ledieu D; Persohn E; Billich A; Baumruker T; Mederos y Schnitzler M; Massberg S
Circ Res; 2015 Jul; 117(4):376-87. PubMed ID: 26129975
[TBL] [Abstract][Full Text] [Related]
38. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
[TBL] [Abstract][Full Text] [Related]
39. GSK3beta is a negative regulator of platelet function and thrombosis.
Li D; August S; Woulfe DS
Blood; 2008 Apr; 111(7):3522-30. PubMed ID: 18218855
[TBL] [Abstract][Full Text] [Related]
40. Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
Uemura T; Kawasaki T; Taniguchi M; Moritani Y; Hayashi K; Saito T; Takasaki J; Uchida W; Miyata K
Br J Pharmacol; 2006 May; 148(1):61-9. PubMed ID: 16520742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
